- Entrectinib2020 | First Faculty of Medicine
- Entrectinib in the treatment of patients with ROS1‑positive advanced non‑small cell lung cancer2021 | Publication without faculty affiliation
- Entrectinib and the fight against toxicities – case report2023 | Third Faculty of Medicine
- Testing of NTRK gene fusions - new guidelines for clinical practice in the Czech Republic2020 | First Faculty of Medicine
- Entrectinib v léčbě ROS1 pozitivního pokročilého nemalobuněčného plicního karcinomu a v léčbě solidních nádorů s NTRK fúzí2021 | First Faculty of Medicine
- Nový kinázový inhibitor: entrectinib2020 | Third Faculty of Medicine
- Treatment of tumors with NTRK fusions2021 | First Faculty of Medicine
- Entrectinib reverses cytostatic resistance through the inhibition of ABCB1 efflux transporter, but not the CYP3A4 drug-metabolizing enzyme2020 | Faculty of Pharmacy in Hradec Králové
- Pacient s diseminovaným NSCLC s fúzí ROS1 s téměř kompletní remisí na biologické léčbě - kazuistika2021 | Publication without faculty affiliation